Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
Nelonemdaz (3 trials)
Cerebral Infarction (Phase 2)
Heart Arrest (Phase 2)
Ischemia (Phase 2)
Out-of-Hospital Cardiac Arrest (Phase 2)
Stroke (Phase 2)
Trials (3 total)
Trial APIs (1 total)